Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Pers Med ; 13(8)2023 Aug 09.
Artigo em Inglês | MEDLINE | ID: mdl-37623490

RESUMO

Patellofemoral instability is a prevalent cause of pain and disability in young individuals engaged in athletic activities. Adolescents face a particularly notable risk of patellar dislocation, which can be attributed to rapid skeletal growth, changes in q-angle, ligamentous laxity, higher activity levels, and increased exposure to risk. Specific sports activities carry an elevated risk of patellar dislocation. Younger age and trochlear dysplasia present the highest risk factors for recurrent patellar dislocations. International guidelines recommend conservative therapy following a single patellar dislocation without osteochondral lesions but suggest surgical intervention in recurrent cases. In this study, we have compiled current scientific data on therapy recommendations, focusing on MPFL (medial patellofemoral ligament) reconstruction. We discuss patient selection, surgical indications, graft selection, location and choice of fixation, graft tensioning, and postoperative care.

2.
Seizure ; 70: 12-19, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31234050

RESUMO

PURPOSE: Resective epilepsy surgery based on an invasive EEG-monitors performed with subdural grids (SDG) or depth electrodes (stereo-electroencephalography, SEEG) is considered to be the best option towards achieving seizure-free state in drug-resistant epilepsy. The authors present a meta-analysis, due to the lack of such a study focusing on surgical outcomes originating from SDG- or SEEG-monitors. METHOD: English-language studies published until May 2018, highlighting surgical outcomes were reviewed. Outcome measures including total number of SDG- or SEEG-monitors and resective surgeries; consecutively followed surgical cases; surgical outcomes classified by Engel in overall, temporal/extratemporal and lesional/nonlesional subgroups were analyzed. RESULTS: 19 articles containing 1025 SDG-interventions and 16 publications comprising 974 SEEG-monitors were researched. The rate of resective surgery deriving from SDG-monitoring hovered at 88.8% (95%CI:83.3-92.6%) (I2 = 77.0%;p < 0.001); in SEEG-group, 79.0% (95%CI:70.4-85.7%) (I2 = 72.5%;p < 0.001) was measured. After SDG-interventions, percentage of post-resective follow-up escalated to 96.0% (95%CI:92.0-98.1%) (I2 = 49.1%;p = 0.010), and in SEEG-group, it reached 94.9% (95%CI:89.3-97.6%) (I2 = 80.2%;p < 0.001). In SDG-group, ratio of seizure-free outcomes reached 55.9% (95%CI:50.9-60.8%) (I2 = 54.47%;p = 0.002). Using SEEG-monitor, seizure-freedom occurred in 64.7% (95%CI:59.2-69.8%) (I2 = 11.9%;p = 0.32). Assessing lesional cases, likelihood of Engel I outcome was found in 57.3% (95%CI:48.7%-65.6%) (I2 = 69.9%;p < 0.001), using SDG; while in SEEG-group, it was 71.6% (95%CI:61.6%-79.9%) (I2 = 24.5%;p = 0.225). In temporal subgroup, ratio of seizure-freedom was found to be 56.7% (95%CI:51.5%-61.9%) (I2 = 3.2%;p = 0.412) in SDG-group; whereas, SEEG-group reached 73.9% (95%CI:64.4%-81.6%); (I2 = 0.00%;p = 0.45). Significant differences between seizure-free outcomes were found in overall (p = 0.02), lesional (p = 0.031), and also, temporal (p = 0.002) comparisons. CONCLUSIONS: SEEG-interventions were associated, at least, non-inferiorly, with seizure-freedom compared with SDG-monitors in temporal, lesional and overall subgroups.


Assuntos
Epilepsia Resistente a Medicamentos/cirurgia , Eletrocorticografia , Eletrodos Implantados , Monitorização Neurofisiológica , Procedimentos Neurocirúrgicos , Epilepsia Resistente a Medicamentos/diagnóstico , Eletrocorticografia/instrumentação , Humanos , Monitorização Neurofisiológica/instrumentação , Convulsões/diagnóstico , Convulsões/cirurgia , Resultado do Tratamento
3.
JBJS Essent Surg Tech ; 8(2): e11, 2018 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-30233983

RESUMO

BACKGROUND: Solitary trochleoplasty for recurrent patellar dislocation offers a unique benefit in that it addresses the most important factor in patellar instability: the trochlear dysplasia. DESCRIPTION: The trochlea is visualized through a lateral arthrotomy of the knee joint. An osteochondral layer is peeled off with curved chisels and extended into the intercondylar notch. A triangular bone block is removed from the subchondral bone to form the new groove. A new groove is begun with a chisel and smoothed with a high-speed burr. Also, the osteochondral layer is thinned out and fixed back transosseously in the new groove with 2 Vicryl (polyglactin) bands. The bone block is used to lengthen the lateral condyle by placing it under the osteochondral layer at the proximal extension of the lateral femoral condyle with an overlap of 1 cm. ALTERNATIVES: Nonsurgical alternatives include a knee or patellar brace, taping of the patella, and physiotherapy for strengthening of the vastus medialis obliquus of the quadriceps muscle. Surgical alternatives include reconstruction of the medial patellofemoral ligament; several femoral and tibial osteotomies, such as rotational osteotomies of the femur and tibia or medialization of the tibial tuberosity; and several soft-tissue interventions, such as medial reefing, relocation of the patellar tendon as described by Goldthwait1, and proximal realignments according to the method described by Insall et al.2 or Green et al.3. RATIONALE: Most patients with recurrent patellar dislocation have a dysplastic trochlea4, which is considered to be the primary reason for a recurrence. While interventions such as reconstruction of the medial patellofemoral ligament or femoral and tibial osteotomies also provide stability of the patella, they do not change the most essential factor of the instability-the trochlear dysplasia. The trochleoplasty addresses this underlying condition and reshapes the trochlea.

5.
Case Rep Gastroenterol ; 9(1): 56-61, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25802499

RESUMO

Autoimmune pancreatitis is a rare but important differential diagnosis from pancreatic cancer. This autoimmune disease can mimic pancreatic cancer by its clinical symptoms, including weight loss and jaundice. Furthermore imaging findings may include a mass of the pancreas. Here we present the case of a 67-year-old male patient diagnosed with autoimmune pancreatitis but showing the well-known symptoms of pancreatic cancer. This emphasizes the difficulties of histological findings and the importance of the correct diagnostic process.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA